Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis?
Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response.
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?
Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading.
(+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?
Multiple Sclerosis (MS) as a demyelinating disease: a review on neurosurgical approaches.
Ambulation and multiple sclerosis.
Nurr1 reduction influences the onset of chronic EAE in mice.
Behavioral experiences as drivers of oligodendrocyte lineage dynamics and myelin plasticity.
Erratum to: Association Between the Single Nucleotide Polymorphism and the Level of Aquaporin-4 Protein Expression in Han and Minority Chinese with Inflammatory Demyelinating Diseases of the Central Nervous System.
Novel MRI and PET markers of neuroinflammation in multiple sclerosis.
Alpha-B-crystallin induces an immune-regulatory and antiviral microglial response in preactive multiple sclerosis lesions.
Diffusion tensor magnetic resonance imaging may show abnormalities in the normal-appearing cervical spinal cord from patients with multiple sclerosis.
Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 Expression.
CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4.
Possible Role of Staphylococcal Enterotoxin B in the Pathogenesis of Autoimmune Diseases.
Time-Lapse Imaging of Glial-Axonal Interactions.
An MRI review of acquired corpus callosum lesions.
Bilateral Surgical Reconstruction for Internal Jugular Veins Disease in Patients With Chronic Cerebrospinal Venous Insufficiency and associated Multiple Sclerosis.
Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis (MS-STAT)
IL-27 Limits Central Nervous System Viral Clearance by Promoting IL-10 and Enhances Demyelination.
In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response.
Bringing CLARITY to gray matter atrophy.
Pages
« first
‹ previous
…
417
418
419
420
421
422
423
424
425
…
next ›
last »